Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19264 | 514 | 34.3 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
1 | 3 | CHEMISTRY, ORGANIC//TETRAHEDRON LETTERS//JOURNAL OF ORGANIC CHEMISTRY | 237069 |
288 | 2 | CHEMISTRY, ORGANIC//ALLYLATION//TETRAHEDRON LETTERS | 18901 |
19264 | 1 | ERIBULIN//ERIBULIN MESYLATE//HALICHONDRIN B | 514 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ERIBULIN | authKW | 2141315 | 11% | 64% | 56 |
2 | ERIBULIN MESYLATE | authKW | 2138624 | 7% | 100% | 36 |
3 | HALICHONDRIN B | authKW | 612815 | 3% | 74% | 14 |
4 | E7389 | authKW | 422442 | 2% | 89% | 8 |
5 | HALAVEN | authKW | 305516 | 1% | 86% | 6 |
6 | MICROTUBULE DYNAMICS INHIBITOR | authKW | 297031 | 1% | 100% | 5 |
7 | POLYETHER MACROLIDE | authKW | 223909 | 1% | 54% | 7 |
8 | GEMINAL DICHROMIUM REAGENT | authKW | 178219 | 1% | 100% | 3 |
9 | NOZAKI HIYAMA ALLYLATION | authKW | 178219 | 1% | 100% | 3 |
10 | NSC 707389 | authKW | 178219 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Organic | 5239 | 46% | 0% | 234 |
2 | Oncology | 660 | 20% | 0% | 103 |
3 | Chemistry, Multidisciplinary | 468 | 22% | 0% | 111 |
4 | Chemistry, Medicinal | 81 | 4% | 0% | 23 |
5 | Pharmacology & Pharmacy | 77 | 10% | 0% | 50 |
6 | Chemistry, Inorganic & Nuclear | 42 | 4% | 0% | 22 |
7 | Chemistry, Applied | 10 | 2% | 0% | 11 |
8 | Crystallography | 1 | 1% | 0% | 5 |
9 | Integrative & Complementary Medicine | 0 | 0% | 0% | 1 |
10 | Mycology | 0 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SYNTH BIOORGANUMR 7175 | 118812 | 0% | 100% | 2 |
2 | TEXAS ONCOL DALLAS P BYTERIAN HOSP | 118812 | 0% | 100% | 2 |
3 | AGENCE FRANCAISE SECURITE SANIT PROD SANTE | 59406 | 0% | 100% | 1 |
4 | ALLEGHENY 2 | 59406 | 0% | 100% | 1 |
5 | BIOL TSUKUBA | 59406 | 0% | 100% | 1 |
6 | CANC TREATMENT DIAGHIH | 59406 | 0% | 100% | 1 |
7 | CANDIDATE ASSESSMENT IN VITRO TECHNOL | 59406 | 0% | 100% | 1 |
8 | DATA MANAGER CLIN GRP | 59406 | 0% | 100% | 1 |
9 | DEP RN | 59406 | 0% | 100% | 1 |
10 | DIPARTIMENTO FARMACO AZIENDA SANIT FIRENZE | 59406 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FUTURE ONCOLOGY | 8271 | 3% | 1% | 14 |
2 | TETRAHEDRON LETTERS | 4916 | 15% | 0% | 78 |
3 | ORGANIC LETTERS | 3345 | 7% | 0% | 38 |
4 | SYNLETT | 1831 | 4% | 0% | 21 |
5 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 1150 | 0% | 1% | 2 |
6 | JOURNAL OF BREAST CANCER | 940 | 1% | 1% | 3 |
7 | INVESTIGATIONAL NEW DRUGS | 828 | 1% | 0% | 6 |
8 | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | 699 | 7% | 0% | 34 |
9 | CLINICAL BREAST CANCER | 691 | 1% | 0% | 3 |
10 | ADVANCED SYNTHESIS & CATALYSIS | 536 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERIBULIN | 2141315 | 11% | 64% | 56 | Search ERIBULIN | Search ERIBULIN |
2 | ERIBULIN MESYLATE | 2138624 | 7% | 100% | 36 | Search ERIBULIN+MESYLATE | Search ERIBULIN+MESYLATE |
3 | HALICHONDRIN B | 612815 | 3% | 74% | 14 | Search HALICHONDRIN+B | Search HALICHONDRIN+B |
4 | E7389 | 422442 | 2% | 89% | 8 | Search E7389 | Search E7389 |
5 | HALAVEN | 305516 | 1% | 86% | 6 | Search HALAVEN | Search HALAVEN |
6 | MICROTUBULE DYNAMICS INHIBITOR | 297031 | 1% | 100% | 5 | Search MICROTUBULE+DYNAMICS+INHIBITOR | Search MICROTUBULE+DYNAMICS+INHIBITOR |
7 | POLYETHER MACROLIDE | 223909 | 1% | 54% | 7 | Search POLYETHER+MACROLIDE | Search POLYETHER+MACROLIDE |
8 | GEMINAL DICHROMIUM REAGENT | 178219 | 1% | 100% | 3 | Search GEMINAL+DICHROMIUM+REAGENT | Search GEMINAL+DICHROMIUM+REAGENT |
9 | NOZAKI HIYAMA ALLYLATION | 178219 | 1% | 100% | 3 | Search NOZAKI+HIYAMA+ALLYLATION | Search NOZAKI+HIYAMA+ALLYLATION |
10 | NSC 707389 | 178219 | 1% | 100% | 3 | Search NSC+707389 | Search NSC+707389 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SWAMI, U , SHAH, U , GOEL, S , (2015) ERIBULIN IN CANCER TREATMENT.MARINE DRUGS. VOL. 13. ISSUE 8. P. 5016 -5058 | 55 | 86% | 4 |
2 | JACKSON, KL , HENDERSON, JA , PHILLIPS, AJ , (2009) THE HALICHONDRINS AND E7389.CHEMICAL REVIEWS. VOL. 109. ISSUE 7. P. 3044-3079 | 63 | 60% | 58 |
3 | WANG, G , SUN, ST , MAO, Y , XIE, ZY , LIU, L , (2016) CHROMIUM(II)-CATALYZED ENANTIOSELECTIVE ARYLATION OF KETONES.BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY. VOL. 12. ISSUE . P. 2771 -2775 | 38 | 88% | 0 |
4 | HARGADEN, GC , GUIRY, PJ , (2007) THE DEVELOPMENT OF THE ASYMMETRIC NOZAKI-HIYAMA-KNISHI REACTION.ADVANCED SYNTHESIS & CATALYSIS. VOL. 349. ISSUE 16. P. 2407-2424 | 37 | 86% | 80 |
5 | YAN, WM , LI, ZJ , KISHI, Y , (2015) SELECTIVE ACTIVATION/COUPLING OF POLYHALOGENATED NUCLEOPHILES IN NI/CR-MEDIATED REACTIONS: SYNTHESIS OF C1-C19 BUILDING BLOCK OF HALICHONDRIN BS.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 137. ISSUE 19. P. 6219 -6225 | 33 | 85% | 1 |
6 | INOUE, M , SUZUKI, T , KINOSHITA, A , NAKADA, M , (2008) CATALYTIC ASYMMETRIC NOZAKI-HIYAMA REACTIONS WITH A TRIDENTATE BIS(OXAZOLINYL)CARBAZOLE LIGAND.CHEMICAL RECORD. VOL. 8. ISSUE 3. P. 169-181 | 43 | 72% | 25 |
7 | LI, JW , YAN, WM , KISHI, Y , (2015) UNIFIED SYNTHESIS OF C1-C19 BUILDING BLOCKS OF HALICHONDRINS VIA SELECTIVE ACTIVATION/COUPLING OF POLYHALOGENATED NUCLEOPHILES IN (NI)/CR-MEDIATED REACTIONS.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 137. ISSUE 19. P. 6226 -6231 | 35 | 74% | 1 |
8 | ASEYEV, O , RIBEIRO, JM , CARDOSO, F , (2016) REVIEW ON THE CLINICAL USE OF ERIBULIN MESYLATE FOR THE TREATMENT OF BREAST CANCER.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 17. ISSUE 4. P. 589 -600 | 33 | 70% | 1 |
9 | GUO, HB , DONG, CG , KIM, DS , URABE, D , WANG, JS , KIM, JT , LIU, X , SASAKI, T , KISHI, Y , (2009) TOOLBOX APPROACH TO THE SEARCH FOR EFFECTIVE LIGANDS FOR CATALYTIC ASYMMETRIC CR-MEDIATED COUPLING REACTIONS.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 131. ISSUE 42. P. 15387 -15393 | 33 | 80% | 37 |
10 | ESLAMIAN, G , WILSON, C , YOUNG, RJ , (2017) EFFICACY OF ERIBULIN IN BREAST CANCER: A SHORT REPORT ON THE EMERGING NEW DATA.ONCOTARGETS AND THERAPY. VOL. 10. ISSUE . P. 773 -779 | 29 | 83% | 0 |
Classes with closest relation at Level 1 |